<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>EAGER:  Nanoparticle-Based Integrated Microsystem for Selective Targeting of Bio-Species in Flowing Suspensions</AwardTitle>
<AGENCY>NSF</AGENCY>
<AwardEffectiveDate>08/15/2009</AwardEffectiveDate>
<AwardExpirationDate>07/31/2012</AwardExpirationDate>
<AwardTotalIntnAmount>149934.00</AwardTotalIntnAmount>
<AwardAmount>149934</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07010000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>ECCS</Abbreviation>
<LongName>Div Of Electrical, Commun &amp; Cyber Sys</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Lawrence Goldberg</SignBlockName>
<PO_EMAI>lgoldber@nsf.gov</PO_EMAI>
<PO_PHON>7032928339</PO_PHON>
</ProgramOfficer>
<AbstractNarration>The objective of this research is to develop a high-performance system to target individual bio-species with dramatically enhanced specificity and sensitivity. The approach is based on utilizing smart nanoparticles, encapsulating various chemicals and equipped with homing features, to provide a vehicle for pin-point delivery of payloads at a nanoscale with high efficiency. Current systems utilize drugs with very low specificity resulting in serious side effects and poor system response. Organic-inorganic nanoparticles will be functionalized with antibodies for specific binding to circulating tumor cells flowing in complex mixtures to improve the system performance.&lt;br/&gt;The intellectual merit lies in the goal of selectively capturing a rare moving bio target that is still a tremendous engineering challenge. Metastatic cancer cells circulating in the blood stream will be targeted. To meet this challenge, unique trans-membrane cell-cell adhesion molecules are used as receptors. The antibodies on the hybrid nanoparticles, having a liposomal bilayer structure and a silicate surface, are used as homing ligands for selective binding to the target cell receptors.&lt;br/&gt;&lt;br/&gt;The project could have a major impact by applying the proposed methodologies not only to detection but also diagnosis, monitoring and treatment of diseases. An automated immunoassay employed at the point-of-care with enhanced specificity will increase the efficacy of patient treatment helping eradicate diseases such as cancer. The proposed project directly supports the Bio-MEMS educational program currently under development; it incorporates workforce development by providing an opportunity for students to carry out advanced interdisciplinary research. Science education outreach for K-12 and general communities will also be arranged.&lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>08/11/2009</MinAmdLetterDate>
<MaxAmdLetterDate>08/11/2009</MaxAmdLetterDate>
<ARRAAmount/>
<TRAN_TYPE>Grant</TRAN_TYPE>
<CFDA_NUM>47.041</CFDA_NUM>
<NSF_PAR_USE_FLAG>0</NSF_PAR_USE_FLAG>
<FUND_AGCY_CODE>4900</FUND_AGCY_CODE>
<AWDG_AGCY_CODE>4900</AWDG_AGCY_CODE>
<AwardID>0943321</AwardID>
<Investigator>
<FirstName>Linan</FirstName>
<LastName>Jiang</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Linan Jiang</PI_FULL_NAME>
<EmailAddress>jiangl@email.arizona.edu</EmailAddress>
<PI_PHON>5206269826</PI_PHON>
<NSF_ID>000526895</NSF_ID>
<StartDate>08/11/2009</StartDate>
<EndDate/>
<RoleCode>Co-Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Joyce</FirstName>
<LastName>Schroeder</LastName>
<PI_MID_INIT>A</PI_MID_INIT>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Joyce A Schroeder</PI_FULL_NAME>
<EmailAddress>jschroeder@azcc.arizona.edu</EmailAddress>
<PI_PHON>5206261384</PI_PHON>
<NSF_ID>000531676</NSF_ID>
<StartDate>08/11/2009</StartDate>
<EndDate/>
<RoleCode>Co-Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Yitshak</FirstName>
<LastName>Zohar</LastName>
<PI_MID_INIT/>
<PI_SUFX_NAME/>
<PI_FULL_NAME>Yitshak Zohar</PI_FULL_NAME>
<EmailAddress>zohar@email.arizona.edu</EmailAddress>
<PI_PHON>5206268093</PI_PHON>
<NSF_ID>000457623</NSF_ID>
<StartDate>08/11/2009</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>University of Arizona</Name>
<CityName>Tucson</CityName>
<ZipCode>857194824</ZipCode>
<PhoneNumber>5206266000</PhoneNumber>
<StreetAddress>888 N Euclid Ave</StreetAddress>
<StreetAddress2/>
<CountryName>United States</CountryName>
<StateName>Arizona</StateName>
<StateCode>AZ</StateCode>
<CONGRESSDISTRICT>03</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_ORG>AZ03</CONGRESS_DISTRICT_ORG>
<ORG_DUNS_NUM>806345617</ORG_DUNS_NUM>
<ORG_LGL_BUS_NAME>UNIVERSITY OF ARIZONA</ORG_LGL_BUS_NAME>
<ORG_PRNT_DUNS_NUM>072459266</ORG_PRNT_DUNS_NUM>
</Institution>
<Performance_Institution>
<Name><![CDATA[University of Arizona]]></Name>
<CityName>Tucson</CityName>
<StateCode>AZ</StateCode>
<ZipCode>857194824</ZipCode>
<StreetAddress><![CDATA[888 N Euclid Ave]]></StreetAddress>
<CountryCode>US</CountryCode>
<CountryName>United States</CountryName>
<StateName>Arizona</StateName>
<CountryFlag>1</CountryFlag>
<CONGRESSDISTRICT>03</CONGRESSDISTRICT>
<CONGRESS_DISTRICT_PERF>AZ03</CONGRESS_DISTRICT_PERF>
</Performance_Institution>
<FoaInformation>
<Code>0510403</Code>
<Name>Engineering &amp; Computer Science</Name>
</FoaInformation>
<ProgramElement>
<Code>7564</Code>
<Text>CCSS-Comms Circuits &amp; Sens Sys</Text>
</ProgramElement>
<ProgramReference>
<Code>0000</Code>
<Text>UNASSIGNED</Text>
</ProgramReference>
<ProgramReference>
<Code>099E</Code>
<Text>High voltage switching &amp; conversion</Text>
</ProgramReference>
<ProgramReference>
<Code>7916</Code>
<Text>EAGER</Text>
</ProgramReference>
<ProgramReference>
<Code>OTHR</Code>
<Text>OTHER RESEARCH OR EDUCATION</Text>
</ProgramReference>
<Appropriation>
<Code>0109</Code>
<Name>NSF RESEARCH &amp; RELATED ACTIVIT</Name>
<APP_SYMB_ID>040100</APP_SYMB_ID>
</Appropriation>
<FUND_OBLG>2009~149934</FUND_OBLG>
</Award>
</rootTag>
